Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
2025 Q4 -tulosraportti
32 päivää sitten
6,00 SEK/osake
Irtoamispäivä 3.6.
2,75%Tuotto/v

Tarjoustasot

SwedenFirst North Sweden
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q1 -tulosraportti
22.5.
Menneet tapahtumat
2025 Q4 -tulosraportti
2.3.
2025 Q3 -tulosraportti
19.11.2025
2025 Q2 -tulosraportti
29.8.2025
2025 Q1 -tulosraportti
20.5.2025
2024 Q4 -tulosraportti
27.2.2025

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 13 t sitten
    ·
    13 t sitten
    ·
    Growth in March of 28 %, Q1 with a good 900 mill in revenue, an expected margin of at least 11 %. Rarely does one see such numbers, and that from a company with a turnover of over 3 bn SEK. Money machine, in other words 🙂. Still believe the stock is strongly underpriced. Possibly due to skepticism towards the MLM concept Happy Easter to all hopefuls
    52 min sitten
    ·
    52 min sitten
    ·
    Great numbers for March! I had hoped for 30+ growth though... I'm excited to see how IT Works! will impact growth going forward. Since North America is growing by 24 mSEK (from 56 in 2025 to 80 mSEK in 2026) in March, we probably don't see revenue from the It Works merger yet. Perhaps a ketchup effect is in store for us. SkyHigh is probably right that the current share price is due to skepticism towards MLM. Won't ZZ eventually be perceived more as a scalable platform company within modern health than an MLM concept selling dietary supplements? If and when that happens, ZZ will be valued at higher multiples. Looking forward to seeing the Q1 report and April sales figures. Happy Easter!
  • 30.3.
    ·
    30.3.
    ·
    Is there someone who can copy the text from DN here? One is allowed to copy texts as long as one states where it is taken from.
    23 t sitten
    ·
    23 t sitten
    ·
    I understand how you and they think. The fundamentals that you describe so well, that's exactly what I wish they could have "countered" a bit with. Every time new potential customers or partners google ZZ, these "true" articles appear, but no "defense". They then make a quick decision based on these articles. I find it difficult not to get "support" from the management where they tell how they work and are innovative towards research, among other things. If this info was also online, perhaps the new potential customers and partners would evaluate on a slightly different basis. I (rheumatic) and the whole family use a lot of the products, and feel a good difference in the body. So I have no doubt how good the products are. Am both a partner and a shareholder.
    23 t sitten · Muokattu
    ·
    23 t sitten · Muokattu
    ·
    Good to hear that you enjoy the products, that's almost the best part of it all ;-). I am a shareholder myself and a satisfied customer. I share your thought that "true" stories appear online, which scare some. This is where I think the media is unfair, because they sometimes negatively influence something that appears to be good. Unfortunately, I believe this is a condition Zinzino operates under right now, and it will not change for the foreseeable future, regardless of what management says. We must believe and hope (which I guess management also does) that it will be different in the future; that the results speak for themselves, and that previously negative articles and perceptions wither away.
  • 27.3.
    27.3.
    Tämä julkaisu on poistettu.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Everyone in Norway has always been told that we must take our cod liver oil (Orkla) every day - it is healthy and good and will keep you well! Everyone agrees on that and doctors, nurses, politicians, and nutritionists recommend it. Then a group of researchers develops an improved «cod liver oil» they call Balance-oil (Zinzino), and launches a new and simple blood test that shows that their «cod liver oil» actually works as promised. But since such a scientific approach reveals that a typical Western diet, including various omega-3 tablets, does not yield such good results, it is indeed appropriate in the good Nordic spirit of Jante Law to take down those who earn good money by creating the «fatty acid balance» they promise in their customers' cells! Science and human freedom of choice win in the end :)
  • Poistettu
    23.3. · Muokattu
    ·
    Poistettu
    23.3. · Muokattu
    ·
    How nice that the chairman sells 15,000 shares for 130kr and buys back 15,000 for 56kr via options. Poor shareholders.
    24.3.
    ·
    24.3.
    ·
    It is better to pay skilled people with option agreements than with sky-high salaries.
  • 23.3.
    ·
    23.3.
    ·
    For those wondering if this will go up…
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q4 -tulosraportti
32 päivää sitten
6,00 SEK/osake
Irtoamispäivä 3.6.
2,75%Tuotto/v

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 13 t sitten
    ·
    13 t sitten
    ·
    Growth in March of 28 %, Q1 with a good 900 mill in revenue, an expected margin of at least 11 %. Rarely does one see such numbers, and that from a company with a turnover of over 3 bn SEK. Money machine, in other words 🙂. Still believe the stock is strongly underpriced. Possibly due to skepticism towards the MLM concept Happy Easter to all hopefuls
    52 min sitten
    ·
    52 min sitten
    ·
    Great numbers for March! I had hoped for 30+ growth though... I'm excited to see how IT Works! will impact growth going forward. Since North America is growing by 24 mSEK (from 56 in 2025 to 80 mSEK in 2026) in March, we probably don't see revenue from the It Works merger yet. Perhaps a ketchup effect is in store for us. SkyHigh is probably right that the current share price is due to skepticism towards MLM. Won't ZZ eventually be perceived more as a scalable platform company within modern health than an MLM concept selling dietary supplements? If and when that happens, ZZ will be valued at higher multiples. Looking forward to seeing the Q1 report and April sales figures. Happy Easter!
  • 30.3.
    ·
    30.3.
    ·
    Is there someone who can copy the text from DN here? One is allowed to copy texts as long as one states where it is taken from.
    23 t sitten
    ·
    23 t sitten
    ·
    I understand how you and they think. The fundamentals that you describe so well, that's exactly what I wish they could have "countered" a bit with. Every time new potential customers or partners google ZZ, these "true" articles appear, but no "defense". They then make a quick decision based on these articles. I find it difficult not to get "support" from the management where they tell how they work and are innovative towards research, among other things. If this info was also online, perhaps the new potential customers and partners would evaluate on a slightly different basis. I (rheumatic) and the whole family use a lot of the products, and feel a good difference in the body. So I have no doubt how good the products are. Am both a partner and a shareholder.
    23 t sitten · Muokattu
    ·
    23 t sitten · Muokattu
    ·
    Good to hear that you enjoy the products, that's almost the best part of it all ;-). I am a shareholder myself and a satisfied customer. I share your thought that "true" stories appear online, which scare some. This is where I think the media is unfair, because they sometimes negatively influence something that appears to be good. Unfortunately, I believe this is a condition Zinzino operates under right now, and it will not change for the foreseeable future, regardless of what management says. We must believe and hope (which I guess management also does) that it will be different in the future; that the results speak for themselves, and that previously negative articles and perceptions wither away.
  • 27.3.
    27.3.
    Tämä julkaisu on poistettu.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Everyone in Norway has always been told that we must take our cod liver oil (Orkla) every day - it is healthy and good and will keep you well! Everyone agrees on that and doctors, nurses, politicians, and nutritionists recommend it. Then a group of researchers develops an improved «cod liver oil» they call Balance-oil (Zinzino), and launches a new and simple blood test that shows that their «cod liver oil» actually works as promised. But since such a scientific approach reveals that a typical Western diet, including various omega-3 tablets, does not yield such good results, it is indeed appropriate in the good Nordic spirit of Jante Law to take down those who earn good money by creating the «fatty acid balance» they promise in their customers' cells! Science and human freedom of choice win in the end :)
  • Poistettu
    23.3. · Muokattu
    ·
    Poistettu
    23.3. · Muokattu
    ·
    How nice that the chairman sells 15,000 shares for 130kr and buys back 15,000 for 56kr via options. Poor shareholders.
    24.3.
    ·
    24.3.
    ·
    It is better to pay skilled people with option agreements than with sky-high salaries.
  • 23.3.
    ·
    23.3.
    ·
    For those wondering if this will go up…
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

SwedenFirst North Sweden
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q1 -tulosraportti
22.5.
Menneet tapahtumat
2025 Q4 -tulosraportti
2.3.
2025 Q3 -tulosraportti
19.11.2025
2025 Q2 -tulosraportti
29.8.2025
2025 Q1 -tulosraportti
20.5.2025
2024 Q4 -tulosraportti
27.2.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q4 -tulosraportti
32 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q1 -tulosraportti
22.5.
Menneet tapahtumat
2025 Q4 -tulosraportti
2.3.
2025 Q3 -tulosraportti
19.11.2025
2025 Q2 -tulosraportti
29.8.2025
2025 Q1 -tulosraportti
20.5.2025
2024 Q4 -tulosraportti
27.2.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

6,00 SEK/osake
Irtoamispäivä 3.6.
2,75%Tuotto/v

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 13 t sitten
    ·
    13 t sitten
    ·
    Growth in March of 28 %, Q1 with a good 900 mill in revenue, an expected margin of at least 11 %. Rarely does one see such numbers, and that from a company with a turnover of over 3 bn SEK. Money machine, in other words 🙂. Still believe the stock is strongly underpriced. Possibly due to skepticism towards the MLM concept Happy Easter to all hopefuls
    52 min sitten
    ·
    52 min sitten
    ·
    Great numbers for March! I had hoped for 30+ growth though... I'm excited to see how IT Works! will impact growth going forward. Since North America is growing by 24 mSEK (from 56 in 2025 to 80 mSEK in 2026) in March, we probably don't see revenue from the It Works merger yet. Perhaps a ketchup effect is in store for us. SkyHigh is probably right that the current share price is due to skepticism towards MLM. Won't ZZ eventually be perceived more as a scalable platform company within modern health than an MLM concept selling dietary supplements? If and when that happens, ZZ will be valued at higher multiples. Looking forward to seeing the Q1 report and April sales figures. Happy Easter!
  • 30.3.
    ·
    30.3.
    ·
    Is there someone who can copy the text from DN here? One is allowed to copy texts as long as one states where it is taken from.
    23 t sitten
    ·
    23 t sitten
    ·
    I understand how you and they think. The fundamentals that you describe so well, that's exactly what I wish they could have "countered" a bit with. Every time new potential customers or partners google ZZ, these "true" articles appear, but no "defense". They then make a quick decision based on these articles. I find it difficult not to get "support" from the management where they tell how they work and are innovative towards research, among other things. If this info was also online, perhaps the new potential customers and partners would evaluate on a slightly different basis. I (rheumatic) and the whole family use a lot of the products, and feel a good difference in the body. So I have no doubt how good the products are. Am both a partner and a shareholder.
    23 t sitten · Muokattu
    ·
    23 t sitten · Muokattu
    ·
    Good to hear that you enjoy the products, that's almost the best part of it all ;-). I am a shareholder myself and a satisfied customer. I share your thought that "true" stories appear online, which scare some. This is where I think the media is unfair, because they sometimes negatively influence something that appears to be good. Unfortunately, I believe this is a condition Zinzino operates under right now, and it will not change for the foreseeable future, regardless of what management says. We must believe and hope (which I guess management also does) that it will be different in the future; that the results speak for themselves, and that previously negative articles and perceptions wither away.
  • 27.3.
    27.3.
    Tämä julkaisu on poistettu.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Everyone in Norway has always been told that we must take our cod liver oil (Orkla) every day - it is healthy and good and will keep you well! Everyone agrees on that and doctors, nurses, politicians, and nutritionists recommend it. Then a group of researchers develops an improved «cod liver oil» they call Balance-oil (Zinzino), and launches a new and simple blood test that shows that their «cod liver oil» actually works as promised. But since such a scientific approach reveals that a typical Western diet, including various omega-3 tablets, does not yield such good results, it is indeed appropriate in the good Nordic spirit of Jante Law to take down those who earn good money by creating the «fatty acid balance» they promise in their customers' cells! Science and human freedom of choice win in the end :)
  • Poistettu
    23.3. · Muokattu
    ·
    Poistettu
    23.3. · Muokattu
    ·
    How nice that the chairman sells 15,000 shares for 130kr and buys back 15,000 for 56kr via options. Poor shareholders.
    24.3.
    ·
    24.3.
    ·
    It is better to pay skilled people with option agreements than with sky-high salaries.
  • 23.3.
    ·
    23.3.
    ·
    For those wondering if this will go up…
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

SwedenFirst North Sweden
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt
© 2026 Nordnet Bank AB.
Nordnet | Alvar Aallon katu 5 C, 3. krs | FI-00100 Helsinki